Position in ONC
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$70,052,180
-$1,644,099 QoQ
Shares Held
245,823
+1.8% QoQ
Ownership
0.217%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#21
of 282 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ONC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FIRST TRUST ADVISORS LP holds $2,824,813,122 across 97 Biotechnology names. ONC ranks #17 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
547,132 | $341,158,687 | |
| 2 | INCY |
Incyte Corp
|
1,587,996 | $180,015,226 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
1,829,545 | $159,078,937 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
289,179 | $143,643,884 | |
| 5 | EXEL |
Exelixis, Inc.
|
2,543,353 | $138,383,836 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
421,534 | $126,894,380 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
324,900 | $120,755,583 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
482,061 | $117,994,070 |
All Filings in ONC
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $70,052,180 | 245,823 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $71,696,279 | 241,426 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $38,226,893 | 125,825 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $47,496,987 | 139,410 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $33,971,861 | 140,339 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $60,744,533 | 223,186 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $30,336,400 | 164,238 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $55,595,860 | 247,632 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $35,717,577 | 250,351 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $34,692,150 | 221,831 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $39,632,486 | 219,741 | Shares | Sole | 2024-02-13 | |
| 2022-12-31 | $614,512 | 2,794 | Shares | Sole | 2023-02-09 | |
| 2022-03-31 | $402,472 | 2,134 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $605,257 | 2,234 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,021,482 | 2,814 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,534,402 | 4,471 | Shares | Sole | 2021-10-12 | |
| 2021-03-31 | $3,411,880 | 9,802 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,650,078 | 6,386 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $1,575,133 | 5,499 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $1,087,633 | 5,773 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $661,716 | 5,375 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||